Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,593 GBX | +0.58% | -3.19% | +9.71% |
Apr. 17 | GSK Reports Positive Data for Gonorrhea Treatment Gepotidacin, Shingles Vaccine Shingrix | MT |
Apr. 17 | GSK: positive clinical results for gonorrhea | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.71% | 80.65B | |
+27.42% | 672B | |
+24.52% | 550B | |
-6.94% | 351B | |
+14.95% | 317B | |
+6.45% | 292B | |
+2.77% | 211B | |
-0.02% | 203B | |
-11.71% | 144B | |
-8.42% | 141B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GlaxoSmithKline Opts to Extend Partnership with 23andMe